Article Details

ImaginAb launches trial to study neoadjuvant immunotherapy - Labiotech.eu

Retrieved on: 2022-12-14 15:32:51

Tags for this article:

Click the tags to see associated articles and topics

ImaginAb launches trial to study neoadjuvant immunotherapy - Labiotech.eu. View article details on hiswai:

Excerpt

ImaginAb is a global biotechnology company focused on developing 89Zr crefmirlimab berdoxam (CD8 ImmunoPET) imaging agent and radiopharmaceutical ...

Article found on: www.labiotech.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up